BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23360883)

  • 21. The genetics of inflammatory bowel disease.
    Bonen DK; Cho JH
    Gastroenterology; 2003 Feb; 124(2):521-36. PubMed ID: 12557156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evidence for immunomodulatory effects of probiotic bacteria.
    Ruemmele FM; Bier D; Marteau P; Rechkemmer G; Bourdet-Sicard R; Walker WA; Goulet O
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):126-41. PubMed ID: 19179874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.
    Thompson-Chagoyán OC; Maldonado J; Gil A
    Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inflammatory bowel disease: genotype-fenotype relationship].
    Gómez de la Concha E
    An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host-bacteria interaction in inflammatory bowel disease.
    Knight P; Campbell BJ; Rhodes JM
    Br Med Bull; 2008; 88(1):95-113. PubMed ID: 18931057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: The PROFICEL study.
    Olivares M; Benítez-Páez A; de Palma G; Capilla A; Nova E; Castillejo G; Varea V; Marcos A; Garrote JA; Polanco I; Donat E; Ribes-Koninckx C; Calvo C; Ortigosa L; Palau F; Sanz Y
    Gut Microbes; 2018 Nov; 9(6):551-558. PubMed ID: 29672211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota, probiotics and inflammatory bowel disease.
    Stephani J; Radulovic K; Niess JH
    Arch Immunol Ther Exp (Warsz); 2011 Jun; 59(3):161-77. PubMed ID: 21445715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DQ2 and -DQ8 genotypes in celiac and healthy Libyan children.
    Alarida K; Harown J; Di Pierro MR; Drago S; Catassi C
    Dig Liver Dis; 2010 Jun; 42(6):425-7. PubMed ID: 19819768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
    Bodd M; Kim CY; Lundin KE; Sollid LM
    Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coeliac disease: dissecting a complex inflammatory disorder.
    Sollid LM
    Nat Rev Immunol; 2002 Sep; 2(9):647-55. PubMed ID: 12209133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory bowel disease.
    Boirivant M; Cossu A
    Oral Dis; 2012 Jan; 18(1):1-15. PubMed ID: 21564424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteria in the pathogenesis of inflammatory bowel disease.
    Flanagan P; Campbell BJ; Rhodes JM
    Biochem Soc Trans; 2011 Aug; 39(4):1067-72. PubMed ID: 21787349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel disease and celiac disease: overlaps in the pathology and genetics, and their potential drug targets.
    Festen EA; Szperl AM; Weersma RK; Wijmenga C; Wapenaar MC
    Endocr Metab Immune Disord Drug Targets; 2009 Jun; 9(2):199-218. PubMed ID: 19519468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.
    Pietzak MM; Schofield TC; McGinniss MJ; Nakamura RM
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):966-71. PubMed ID: 19500688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The genetic basis of inflammatory bowel disease unravelled by genetic association studies].
    Visschedijk MC; Festen EA; Wijmenga C; Weersma RK
    Ned Tijdschr Geneeskd; 2009; 153():A402. PubMed ID: 19900309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiome and Gluten.
    Sanz Y
    Ann Nutr Metab; 2015; 67 Suppl 2():28-41. PubMed ID: 26605783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects.
    Megiorni F; Mora B; Bonamico M; Barbato M; Montuori M; Viola F; Trabace S; Mazzilli MC
    Am J Gastroenterol; 2008 Apr; 103(4):997-1003. PubMed ID: 18177450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.